{"paper_id":"75d39fc5-0ac1-4c66-aaf9-2774901e87bf","body_text":"Data availability\nNot applicable.\nReferences\nBiedroń G, Wil M, Nowakowski J et al (2024) Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort study. Rheumatol Int. https://doi.org/10.1007/s00296-024-05632-2\nLewinson RT, Vallerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG et al (2017) Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study. J Invest Dermatol 137(4):828–835\nZhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ (2020) Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol 39(1):217–225\nThomsen RS, Nilsen TIL, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M (2021) Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway. Arthritis Care Res 73(3):432–441\nCoates LC, Bukhari M, Chan A et al (2024) Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatol (Oxford) Mar 15:keae172\nElsawy NA, Helal AMH, Abd ElHamid HA, Abdel-Fattah YH (2021) Fibromyalgia in patients with psoriatic arthritis: impact on disease activity indices, fatigue and health-related quality of life. Int J Rheum Dis 24(2):189–196\nHarris HR, Korkes KMN, Li T et al (2022) Endometriosis, psoriasis and psoriatic arthritis: a prospective cohort study. Am J Epidemiol 191:1050–1060\nSymons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, Tayade C (2018) The immunopathophysiology of endometriosis. Trends Mol Med 24:748–762\nEisenberg VH, Zolti M, Soriano D (2012) Is there an association between autoimmunity and endometriosis? Autoimmun Rev 11:806–814\nZervou MI, Goulielmos GN (2024) Comment on: enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatol (Oxford) May 17:keae\nKotlyar AM, Mamillapalli R, Flores VA et al (2021) Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression. Mol Hum Reprod 27:gaab016\nAcknowledgements\nNot applicable.\nFunding\nThe authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.\nAuthor information\nAuthors and Affiliations\nContributions\nM.I.Z. and G.N.G. designed the current study, searched the literature and drafted the manuscript.\nCorresponding author\nEthics declarations\nConflict of interest\nThe authors have declared no conflicts of interest.\nAdditional information\nPublisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nAbout this article\nCite this article\nZervou, M.I., Goulielmos, G.N. Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: the case of endometriosis. Rheumatol Int 44, 1801–1802 (2024). https://doi.org/10.1007/s00296-024-05666-6\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00296-024-05666-6","source_license":"CC0","license_restricted":false}